ACTIVE

ROMAPHARM

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

140,9 k €

-27.4% YoY

Gross margin

605,3 k €

-10.4% YoY

Equity

2,3 M €

+6.6% YoY

Workforce

5,6 ETP

+5.7% YoY

What does ROMAPHARM do?

ROMAPHARM is a Public limited company incorporated in 1995. Its registered office is in Koksijde. It employs on average 5,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0456.909.689

Incorporation

22/12/1995

Legal form

Public limited company

Registered office

Koninklijke Baan(Kok) 102
8670 Koksijde · FlandreSee on map

Contributed capital

172 000,00 €

Latest accounts

31/12/2025

Average workforce

5,6 ETP

Joint committees (4)

201
20100
313
31300

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	605,3 k €	-10.4%	675,4 k €	-8.3%	736,4 k €	-2.4%	754,9 k €	-8.6%	826,3 k €	+12.0%	737,5 k €	+8.3%	681,3 k €	+25.4%	543,3 k €	-11.6%	614,8 k €	-5.5%	650,7 k €	+9.3%	595,3 k €	-2.7%	611,6 k €	+4.9%	583 k €	-13.3%	672,2 k €	+9.8%	612,3 k €	+14.0%	537 k €	+7.5%	499,5 k €	+10.3%	452,8 k €	-1.1%	457,7 k €	-11.4%	516,3 k €
EBITDA	301,1 k €	-18.5%	369,7 k €	-17.2%	446,3 k €	+20.7%	369,7 k €	+3.4%	357,7 k €	+19.6%	299 k €	+20.3%	248,5 k €	+56.9%	158,4 k €	-23.7%	207,6 k €	+25.0%	166,1 k €	+17.9%	140,9 k €	-43.4%	249 k €	+9.7%	226,9 k €	-32.5%	336 k €	+12.4%	298,9 k €	+20.1%	248,8 k €	+10.3%	225,5 k €	-5.0%	237,3 k €	+2.6%	231,3 k €	-26.4%	314,4 k €
Operating result	192,6 k €	-25.7%	259,4 k €	-23.9%	341 k €	+29.2%	263,8 k €	+4.8%	251,8 k €	+30.6%	192,8 k €	+37.1%	140,6 k €	+116%	65 k €	+16.6%	55,8 k €	-12.9%	64 k €	+95.2%	32,8 k €	-68.8%	105,2 k €	+15.8%	90,8 k €	-45.3%	166,1 k €	+10.4%	150,4 k €	+36.1%	110,5 k €	+33.6%	82,7 k €	-33.0%	123,4 k €	+32.4%	93,2 k €	-46.8%	175,2 k €
Net result	140,9 k €	-27.4%	194,1 k €	-24.5%	257,1 k €	+28.6%	199,9 k €	+5.5%	189,5 k €	+27.3%	148,8 k €	+55.3%	95,8 k €	+154%	37,7 k €	+28.1%	29,4 k €	-24.8%	39,1 k €	+55.7%	25,1 k €	-66.1%	74,2 k €	+25.9%	58,9 k €	-3.1%	60,8 k €	-60.9%	155,3 k €	+121%	70,2 k €	+55.5%	45,2 k €	+212%	-40,3 k €	-180%	50,1 k €	-51.8%	104 k €
Balance sheet
Equity	2,3 M €	+6.6%	2,1 M €	+10.0%	1,9 M €	+15.2%	1,7 M €	+13.4%	1,5 M €	+14.6%	1,3 M €	+8.2%	1,2 M €	+7.8%	1,1 M €	+2.6%	1,1 M €	+2.8%	1,1 M €	+3.8%	1 M €	+2.5%	994,1 k €	+8.1%	919,9 k €	+1.5%	906 k €	+3.3%	877,4 k €	+13.6%	772,1 k €	+10.0%	701,8 k €	+28.4%	546,7 k €	-6.9%	586,9 k €	+7.7%	544,9 k €
Total assets	3 M €	+3.2%	2,9 M €	+9.6%	2,6 M €	+2.2%	2,6 M €	+5.4%	2,4 M €	+11.4%	2,2 M €	+11.7%	2 M €	-0.9%	2 M €	-11.3%	2,2 M €	+2.8%	2,2 M €	-1.2%	2,2 M €	+4.5%	2,1 M €	+1.1%	2,1 M €	-8.8%	2,3 M €	-5.6%	2,4 M €	-11.9%	2,7 M €	+13.2%	2,4 M €	+33.6%	1,8 M €	+0.4%	1,8 M €	+9.2%	1,6 M €
Cash	344,6 k €	+144%	141 k €	-6.9%	151,3 k €	+18.4%	127,9 k €	-30.7%	184,6 k €	+203%	60,9 k €	+41.7%	43 k €	-47.1%	81,4 k €	-50.0%	162,8 k €	+60.4%	101,6 k €	-51.4%	208,9 k €	+64.3%	127,2 k €	-28.0%	176,6 k €	-11.6%	199,9 k €	+302%	49,7 k €	-64.4%	139,7 k €	-33.6%	210,4 k €	+54.1%	136,5 k €	+67.2%	81,6 k €	+13.4%	72 k €
Debts	682 k €	-6.6%	730,1 k €	+8.9%	670,6 k €	-22.5%	864,9 k €	-6.9%	928,9 k €	+6.7%	870,2 k €	+17.1%	743,4 k €	-12.1%	846,2 k €	-24.8%	1,1 M €	+3.1%	1,1 M €	-5.4%	1,2 M €	+6.5%	1,1 M €	-4.4%	1,1 M €	-15.8%	1,3 M €	-12.1%	1,5 M €	-22.0%	2 M €	+14.5%	1,7 M €	+35.8%	1,3 M €	+4.7%	1,2 M €	+9.6%	1,1 M €
Other
Workforce	5,6 ETP	+5.7%	5,3 ETP	-27.4%	7,3 ETP	0.0%	7,3 ETP	-14.1%	8,5 ETP	+6.3%	8,0 ETP	-3.6%	8,3 ETP	+15.3%	7,2 ETP	-12.2%	8,2 ETP	-8.9%	9,0 ETP	+7.1%	8,4 ETP	+12.0%	7,5 ETP	+8.7%	6,9 ETP	+6.2%	6,5 ETP	-1.5%	6,6 ETP	+10.0%	6,0 ETP	+7.1%	5,6 ETP	+14.3%	4,9 ETP	+4.3%	4,7 ETP	+11.9%	4,2 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 11 ended

Active mandates

DEMARAX

Director · 0890.816.128

Represented by Pascale HOUVENAGHEL

Active

Marceau DECRU

Director

Active

O.P.S.

Managing director · 0476.273.958

Represented by Geert DECRU

Active

Ended mandates

DEMARAX

Director · since 01 août 2007 · 0890.816.128

Represented by Pascale HOUVENAEGHEL

Ended

DEMARAX

Director · 0890.816.128

Represented by Pascale HOUVENAEGHEL

Ended

DEMARAX

Director · 0890.816.128

Ended

DEMARAX

Director · 0890.816.128

Represented by Pascale Houvenaeghel

Ended

At this address

Other companies at this address

Company	CBE no.
Vereniging van Mede-eigenaars Residentie Talassa te Koksijde, Koninklijke Baan 102● Active	0833.568.015

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	10/06/2026	19/04/2025	03/05/2024	24/04/2023	30/06/2022	10/06/2021
General meeting	31/03/2026	21/03/2025	05/04/2024	31/03/2023	31/05/2022	09/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	31/03/2026	10/06/2026	Dutch	PDF
Abridged model	31/12/2024	21/03/2025	19/04/2025	Dutch	PDF
Abridged model	31/12/2023	05/04/2024	03/05/2024	Dutch	PDF
Abridged model	31/12/2022	31/03/2023	24/04/2023	Dutch	PDF
Abridged model	31/12/2021	31/05/2022	30/06/2022	Dutch	PDF
Abridged model	31/12/2020	09/06/2021	10/06/2021	Dutch	PDF
Abridged model	31/12/2019	29/05/2020	02/06/2020	Dutch	PDF
Abridged model	31/12/2018	28/05/2019	06/06/2019	Dutch	PDF
Abridged model	31/12/2017	29/06/2018	16/07/2018	Dutch	PDF
Abridged model	31/12/2016	30/06/2017	13/07/2017	Dutch	PDF
Abridged model	31/12/2015	20/05/2016	09/06/2016	Dutch	PDF
Abridged model	31/12/2014	24/07/2015	24/07/2015	Dutch	PDF
Abridged model	31/12/2013	21/06/2014	18/07/2014	Dutch	PDF
Abridged model	31/12/2012	24/06/2013	05/07/2013	Dutch	PDF
Abridged model	31/12/2011	04/05/2012	07/05/2012	Dutch	PDF
Abridged model	31/12/2010	27/05/2011	31/05/2011	Dutch	PDF
Abridged model	31/12/2009	11/06/2010	14/06/2010	Dutch	PDF
Abridged model	31/12/2008	26/06/2009	20/07/2009	Dutch	PDF
Abridged model	31/12/2007	27/06/2008	04/07/2008	Dutch	PDF
Abridged model	31/12/2006	08/06/2007	26/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 11 ended

Active mandates

DEMARAX

Director · 0890.816.128

Represented by Pascale HOUVENAGHEL

Active

Marceau DECRU

Director

Active

O.P.S.

Managing director · 0476.273.958

Represented by Geert DECRU

Active

Ended mandates

DEMARAX

Director · since 01 août 2007 · 0890.816.128

Represented by Pascale HOUVENAEGHEL

Ended

DEMARAX

Director · 0890.816.128

Represented by Pascale HOUVENAEGHEL

Ended

DEMARAX

Director · 0890.816.128

Ended

DEMARAX

Director · 0890.816.128

Represented by Pascale Houvenaeghel

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates06/08/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/05/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
PDF
Mandates26/10/2018
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares18/01/2012
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
PDF
Capital / shares03/11/2009
KAPITAAL - AANDELEN
PDF
Mandates29/07/2008
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/10/2005
ONTSLAGEN - BENOEMINGEN
PDF
Registered office16/04/2004
ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - MAATSCHAPPELIJKE ZETEL
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025140,9 k €↓
2024
Annual accounts 2024194,1 k €↓
2023
Annual accounts 2023257,1 k €↑
2022
Annual accounts 2022199,9 k €↑
2021
Annual accounts 2021189,5 k €↑
2020
Annual accounts 2020148,8 k €↑
2019
Annual accounts 201995,8 k €↑
2018
Annual accounts 201837,7 k €↑
2017
Annual accounts 201729,4 k €↓
2016
Annual accounts 201639,1 k €↑
2015
Annual accounts 201525,1 k €↓
2014
Annual accounts 201474,2 k €↑
2013
Annual accounts 201358,9 k €↓
2012
Annual accounts 201260,8 k €↓
2011
Annual accounts 2011155,3 k €↑
2010
Annual accounts 201070,2 k €↑
2009
Annual accounts 200945,2 k €↑
2008
Annual accounts 2008-40,3 k €↓
2007
Annual accounts 200750,1 k €↓
2006
Annual accounts 2006104 k €
22/12/1995
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

ROMAPHARM

Overview

What does ROMAPHARM do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline